Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
MBRP
1 other identifier
interventional
168
1 country
7
Brief Summary
Alcohol use disorder (AUD) is the second highest preventable cause of death in France. Only 3% of patients are prescribed approved drugs for reducing alcohol consumption or maintenance of abstinence. Increasing evidence supports the efficacy of psychotherapies such as cognitive and behavioral therapies (CBT) in AUD. However, some patients are resistant to CBT and the positive effects of CBT could wane over time, resulting in mid- and long-term relapses. Mindfulness practice is increasingly widespread in the United States and its efficacy in various fields appears very promising. The study investigators hypothesize that the Mindfulness Based Relapse Prevention (MBRP) program will be more efficient than a relaxation/meditation without guidance control program in AUD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
October 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
ExpectedAugust 21, 2025
August 1, 2025
4.2 years
October 16, 2020
August 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in number of heavy drinking days (HDD) over previous 4 weeks, between the last drinking period at inclusion and 6 months.
Alcohol Time Line Follow Back (TLFB) where a HDD = consummation of 4+ (for women) or 5+ (for men) drinks per day.
6 months
Secondary Outcomes (40)
Change in number of heavy drinking days (HDD) during the last 4 weeks, between the last drinking period at inclusion and 3 months between groups
3 months
Change in number of heavy drinking days (HDD) during the last 4 weeks, between the last drinking period at inclusion and 12 months between groups
12 months
Change in 4-week total alcohol consumption since baseline
3 months
Change in 4-week total alcohol consumption since baseline
12 months
Change in frequency of craving since baseline
3 months
- +35 more secondary outcomes
Study Arms (2)
MBRP program:
EXPERIMENTALStandard care
ACTIVE COMPARATORInterventions
7 x 60-120 minute sessions with different themes: Automatic pilot/triggers/relapse/high-risk situations/ mindfulness in daily life. There will be a welcoming time, with a focus on at-home practice and difficulties, a theoretical presentation of new concepts, practical meditation exercises and a debriefing.
7 x 60-120 minute sessions each with a different sound from nature with unguided, closed relaxation group with a maximum of 12 participants
Eligibility Criteria
You may qualify if:
- Having a moderate to severe alcohol use disorder according to DSM 5 criteria.
You may not qualify if:
- Severe depression (Beck Depression Inventory\> 30)
- Schizophrenic disorder,
- Current maniac or hypomaniac episode,
- Patient with dementia or severe cognitive impairment that would prevent him/her from following the course of a session, as judged by the clinician.
- Insufficient French understanding to complete the questionnaires
- Pregnant or breastfeeding woman
- Absence of social security regimen
- Other mindfulness-based structured therapies
- Refusal to sign the written consent. • The patient is under safeguard of justice or state guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Ssra Les Eumenides
Angers, 49100, France
Hôpital Corentin-Celton
Issy-les-Moulineaux, France
CHU de Nantes
Nantes, France
CHU de Nimes
Nîmes, France
Hopital Fernand Widal
Paris, 75010, France
Hopital Des 4 Villes
Sèvres, 92310, France
Hopital Paul Brousse
Villejuif, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amandine Luquiens
CHU Nimes
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- In order to limit measurement and attrition biases, the patient will be kept unaware of the hypotheses concerning the details of the evaluated programs (MBRP or control) and the program expected to be superior
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2020
First Posted
October 22, 2020
Study Start
October 20, 2021
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
August 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share